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Abstract:
 
The problem of nipple-areola complex (NAC) preservation during mastectomy is a very intriguing and stimulating
issue. In fact, in order to perform an oncologically safe operation, no mammary tissue (enclosed in the main galactophoric ducts)
should remain; on the other hand, without the blood supply coming from the breast gland, NAC viability is greatly impaired because
the surrounding vascular dermal network is not developed enough to support its metabolic requirements. We suggest therefore a
two-step surgical procedure. The first step, on an outpatient basis with local tumescent anesthesia, is a mini-invasive cutting and
coagulating procedure. It addresses the autonomization of the vascular supply to the NAC by detaching the galactophore stalk from
the nipple and coagulating the deep vascular plexus. The second step, under general anesthesia and again with tumescent technique,
removes the breast within its capsule, with careful checks of any remnant and adequate approach to the axilla. A subpectoralis
prosthesis completes the procedure. In our view, this technique is electively suitable for prophylactic mastectomy, but also for stage
I breast cancer, 2.5 cm from the NAC and 1.5 cm from the skin and pectoralis fascia, and it is very safe, simple, and effective.
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T
 
he inheritable breast cancer recently detectable by
evidence of the 
 
BRCA-1
 
/
 
BRCA-2
 
 gene mutation, lob-
ular hyperplasia, atypical ductal hyperplasia, and lobular
carcinoma in situ are currently faced on a preventive basis
with selective screening and follow-up, chemoprevention,
and/or prophylactic mastectomy (1–4). The surgical options
of simple mastectomy and subcutaneous mastectomy—
the former excising the nipple-areola complex (NAC)
together with the gland, the latter leaving intact the NAC—
provides 95–99% and 90–95% breast tissue removal,
respectively, and thus being inadequate as to oncologic
radicality (5). Therefore when risk of breast cancer is high,
total mastectomy is the golden standard.
A 13% increase (from 81% to 94%) of total mastecto-
mies in cohorts of women with a family history of breast
malignancy has been observed since 1995, followed by an
high rate of reconstruction. Metcalfe et al. (6) report
breast restoration in 60% of these patients, compared
with 6–13% of nonprophylactic mastectomies.
Our study addresses the hypothesis of a new radical
approach to subcutaneous mastectomy while retaining
the integrity of the NAC, without leaving any gland stalk
or parenchyma underneath, and thus obtaining complete
clearance of the breast tissue. Primary reconstruction with
subpectoralis prosthesis or two-stage replacement with an
expander are the surgical options to complete the proced-
ure in order to achieve satisfactory cosmetic results. This
procedure addresses both cancer prophylaxis and stage I
cancer treatment.
 
MATERIALS AND METHODS
 
From April 1999 to August 2004, we operated on 18
women (Table 1), age 29–62 years, recruited on the basis
of the following guidelines: T1 cancer, 2.5 cm from the
NAC and at least 1.5 cm from the skin and pectoralis
fascia. All patients signed an informed consent form with
analytical details of the procedure. The procedure was
divided into two different phases: NAC vascular auto-
nomization on an outpatient basis using local tumescent
anesthesia with laparoscopic instrumentation; and delayed
nipple-sparing modified subcutaneous mastectomy using
general anesthesia with tumescent technique plus subpec-
toralis textured silicone breast implant.
 
Address correspondence and reprint requests to: Beniamino Palmieri, MD, University of Modena and Reggio Emilia, Department of General Surgery and Surgical Specialty, Surgical Clinics, Via del Pozzo 71, 41100 Modena, Italy, or e-mail: palmieri@unimo.it.
 174
 
•
 
palmieri et al
 
.
 
Details of the Procedure
 
Phase 1 consists of premedication with diazepam 10
mg intramuscularly, tramadol 100 mg, and cefazolin 1 g
(Fig. 1A). In the supine position, the areola-periareolar
subcutaneous tissue (each side) is infiltrated using a 21-
gauge needle with anesthetic solution: 1% Carbocaine
and epinephrine (1:1000) in 20 ml and 80 ml saline with
10 ml sodium bicarbonate (1:16) (Fig. 1B).
The orange-peel skin is obtained over a 20 cm diame-
ter. After 20 minutes, when the skin is blanched due to
vasoconstrictor effect, a 5 mm hole is placed 18 cm from
the nipple with a no. 11 blade along the line of approach for
the final operation. Electrified laparoscopic scissors are
then introduced through this small incision and dissection
of the periareolar skin and nipple-areola from the breast
gland stalk is completed on a very surficial subcutaneous
plane (Fig. 1C). The breast parenchyma is totally severed
from the skin and coagulated, leaving only the dermal
vascular network to supply the NAC.
Great care is taken to avoid skin overheating or burn-
ing: sponges filled with cold water are applied to the skin
surface and cold saline irrigation mixed with 1 g chloram-
phenicol powder is introduced in the subcutaneous space
(Fig. 1D).
Careful hemostasis control follows this step, with dry
gauze strips introduced into the wound up to the sub-
areolar dead space to detect and stop any blood leaking.
Microscopic examination of the major ductal breast stalk
is now possible to evaluate potential tumor seeding.
Finally, six to eight fine strips of collagen (5 cm 
 
×
 
 0.5
cm) with gentamicin are inserted to insulate the recently
dissected deep subcutaneous surface from the vascular
network of the cut gland (Fig. 1E). A single Ethilon stitch
is used to close the skin.
The breasts are wrapped in an elastic bandage. The
patient is given analgesic and antibiotic prescriptions for
3 days. Stitch removal is performed 6 days later.
Phase 2 occurs 3 weeks later, when the patient is admit-
ted to the hospital for the final mastectomy or mastectomy
plus lymphadenectomy. Under general anesthesia, the
breast subcutaneous fat close to the dermis (bilaterally) is
infiltrated with saline solution (250 ml each) with anti-
biotic and 0.25 mg epinephrine, producing a widespread
orange-peel skin appearance.
When the surface starts to be pale due to vasoconstric-
tion, a 12–15 cm incision is made, either vertically between
the internal and external quadrants or laterally between
the upper and lower quadrants (Fig. 2A). In cases where
a previous scar exists, the incision overlaps it to minimize
vascular injury to the NAC.
The surgeon reaches the breast capsule and starts
detaching it from the subcutaneous stroma with blunt dis-
section and coagulation, paying attention not to overheat
the dermal vessels and to avoid tearing the capsule (Fig. 2B).
Special care is taken with the axillary prolongation
excision; in the case of axillary and/or sentinel lymph node
dissection, the lateral incision is preferred because of the
optimal vessels and nerve exposure.
When the dead subareolar space is approached, the
surgeon checks the inner surface of the nipple-areola as
well as the coagulated breast gland stalk to clear loose
collagenic adhesions; at this time subcutaneous biopsy
of the nipple remnant is performed and samples of
Table 1. Patient Information
 
Patient no. Age Description
1 34 Left contralateral lobular cancer. The patient had a previous right quadrantectomy and radiotherapy) (pT1N0M0)
2 42 Left breast cancer and fibrocystic mastopathy with axillary metastasis who refused total mastectomy (bilateral) (pT1N1M0)
3 37 Fibrocystic mastopathy and familiar breast cancer (bilateral)
4 39 Bilateral previous quadrantectomy plus previous radiation therapy to one side (bilateral)
5 62 Breast dysplasia and previous contralateral mastectomy
6 42 Severe bilateral relapsing mastitis (bilateral)
7 51 Lobular carcinoma in situ (left breast) and ductal carcinoma in situ (right) (bilateral)
8 56 Right lower lateral quadrant ductal infiltrating carcinoma (pT1N0M0)
9 44 Painful fibrocystic disease and breast cancer in mother and older sister (bilateral)
10 37 Right infiltrating ductal carcinoma (pT1N1M0)
11 42 Right breast infiltrating ductal carcinoma (pT1N1M0)
12 61 Right breast comedo carcinoma (pT1N1M0)
13 58 Right breast infiltrating ductal carcinoma (pT1N0M0)
14 29 Right breast lobular carcinoma (pT1N1M0)
15 48 Right breast infiltrating ductal carcinoma (pT1N0M0)
16 30 Cystic mastopathy and family cancer (bilateral)
17 35 Left breast solid carcinoma (pT1N1M0)
18 45 Right breast infiltrating ductal carcinoma (pT1N0M0)
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the galactophoric stalk are prepared and sent to the
pathologist.
Finally, after having removed the subcutaneous surface
of the breast capsule, it is possible to draw out the entire
gland (Fig. 2C). The pectoralis fascia is preserved or
excised, with accurate control of the bleeding (Fig. 2D).
At this point, a very accurate bench examination of the
breast is done (Fig. 2E), with special attention to the
capsule integrity, then a second look with breast skin
fiberoptic transillumination or a laparoscopic camera is
performed to be sure that no remnants or succenturiate
lobules have been inadvertently left in place. In case of
Figure 1. Phase 1. (A) Cystic mastopathy and ductal infiltrating carcinoma, preoperative view. (B) Local anesthesia and tumescent injection to
induce orange-peel skin. (C) Electrified laparoscopic equipment. (D) Vascular network coagulation and galactophore stalk dissection: the NAC
skin is cooled by wet sponges. (E) Blind final adjustment of the operative field that is covered with several collagen fleeces in order to prevent
regeneration of the cut and coagulated vessels; the collagen is inserted with a small vascular clamp.
 176
 
•
 
palmieri et al
 
.
tumor surgery, 12 surgical biopsies (3 for each quadrant)
of the subcutaneous fat tissue are sent to the pathologist
to confirm the absence of any gland remnant or tumor
cluster. When clearance is confirmed and hemostasis is
achieved, a subpectoralis silicone prosthesis or temporary
skin expander can be placed to prepare the pocket for
reconstruction. Suction drains are inserted and left in
place for 72 hours.
Pectoralis muscle has to be completely detached from
lateral and distal insertion, and a properly sized textured
Figure 2. Phase 2. (A) Lateral incision to achieve the best tumor and axillary exposure: note the NAC viability. (B) Mobilization of the gland capsule
from the dermis thickened by the tumescent technique. (C) The whole breast is delivered from the incision at the end of the deep dissection.
(D) A clean thoracic surface after radical nipple-sparing mastectomy: under the nipple-areola there is only regular dermal tissue whose oncologic
stage can be verified by slide imprint cytology or biopsy. (E) Gross specimen appearance: there is no damage to the breast capsule.
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silicone prosthesis (Eurosilicone, France) is wrapped
within its fibers with absorbable stitches to avoid any
direct contact between the skeletonized skin and the
polysiloxane membrane. Proper skin closure and elastic
bandaging complete the procedure.
 
RESULTS
 
No NAC necrosis has been observed, except in patient
1, during the learning curve training, where overheating
caused heat injury to the skin (Fig. 3). In this patient, the
second operation was postponed 6 weeks to allow good
scar formation and dermal vascular network regenera-
tion. The final outcome was satisfactory. No depigmenta-
tion or other damage to the NAC has ever been observed.
We have also been able to safely lift the NAC during the
reconstruction phase in two cases, allowing us to achieve
symmetry.
In one case (patient 2) we didn’t immediately insert
the prosthesis because of planned chemoradiotherapy.
The NAC was undamaged and the patient is awaiting
reconstruction.
Another case had unilateral delayed nipple-sparing
modified subcutaneous mastectomy and replacement
with prosthesis, but not contralateral mastopexy (Fig. 4).
No local or axillary tumor relapse has been observed,
with an average follow-up of 21 months (range 6–52
months).
 
DISCUSSION
 
Our results show that the two-step delayed nipple-
sparing modified subcutaneous mastectomy is a safe,
simple, and effective procedure to completely remove the
gland with intraoperative direct determination of any pos-
sible remnant. The autonomization of the NAC obtained
Figure 3. (A) Incorrect and (B) correct outcome of NAC autonomization performed by two surgeons on the same patient at the same time:
overheating and burning of the nipple stalk produces coagulative necrosis that heals in 4–8 weeks.
Figure 4. (A) Breast carcinoma detected 2 years after quadrantectomy far from the nipple: the scar of our operation overlaps the previous incision.
(B) The same patient 3 months later: contralateral symmetric adjustment has been planned, but not yet done.
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with blind dissection by means of laparoscopic instru-
ments leaves only the dermal plexus as the main vascular
supply (7). This very fine network is able to guarantee the
integrity of breast skin appendages (assuming that they
are being cut very close to the dermis) and even to mobilize
the nipple-areola if mastopexy is required during
reconstruction.
Hemostasis of detached galactophores, antibiotic
irrigation of the surgical field, and collagen fleece insula-
tion of the deep nipple-areola layer are three main steps to
prevent infections and complications and to induce an
efficient collateral circulation and autonomization of the
overlying skin: vascular reconnection from the breast
gland to the skin is prevented and very loose adhesions are
detected during the second part of the procedure. The
opportunity to do cytologic smears or frozen sections of
both the cut surfaces during the second surgical step gives
further oncologic awareness of radicality, and is why this
technique is also used for stage I breast cancer.
We believe this procedure is another option to classic
skin-preserving mastectomies. This approach should be
considered especially for young women with a high family
cancer risk, because it takes equally into account complete
gland removal and cosmetic reconstruction in a very
simple way.
A two-step surgical approach, the first one being an
office procedure, makes nipple-areola preservation easy
and safe. Furthermore, with this technique, accurate
pathologic details as to the absence of cancer cells under
the NAC are obtained at two different times. The safe
interval between the first and second operation is 2–4
weeks, based on the time required to open the collateral
capillary network and complete the newly formed angio-
genetic processes.
This simple method achieves vascular autonomization
and oncologic safety of the preserved NAC. Wider patient
recruitment and long-term follow-up of this technique are
needed.
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